Global Isothermal Nucleic Acid Amplification Market Research Report 2021

1 Isothermal Nucleic Acid Amplification Market Overview

• 1.1 Product Overview and Scope of Isothermal Nucleic Acid Amplification
• 1.2 Isothermal Nucleic Acid Amplification Segment by Type
  • 1.2.1 Global Isothermal Nucleic Acid Amplification Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 LAMP
  • 1.2.3 HDA
  • 1.2.4 Other
• 1.3 Isothermal Nucleic Acid Amplification Segment by Application
  • 1.3.1 Global Isothermal Nucleic Acid Amplification Sales Comparison by Application: (2021-2027)
  • 1.3.2 Research Use
  • 1.3.3 Foods Inspection
  • 1.3.4 Environment Inspection
• 1.4 Global Isothermal Nucleic Acid Amplification Market Size Estimates and Forecasts
  • 1.4.1 Global Isothermal Nucleic Acid Amplification Revenue 2016-2027
  • 1.4.2 Global Isothermal Nucleic Acid Amplification Sales 2016-2027
  • 1.4.3 Isothermal Nucleic Acid Amplification Market Size by Region: 2016 Versus 2021 Versus 2027

2 Isothermal Nucleic Acid Amplification Market Competition by Manufacturers

• 2.1 Global Isothermal Nucleic Acid Amplification Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Isothermal Nucleic Acid Amplification Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Isothermal Nucleic Acid Amplification Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Isothermal Nucleic Acid Amplification Manufacturing Sites, Area Served, Product Type
• 2.5 Isothermal Nucleic Acid Amplification Market Competitive Situation and Trends
  • 2.5.1 Isothermal Nucleic Acid Amplification Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Isothermal Nucleic Acid Amplification Players Market Share by Revenue
  • 2.5.3 Global Isothermal Nucleic Acid Amplification Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Isothermal Nucleic Acid Amplification Retrospective Market Scenario by Region

• 3.1 Global Isothermal Nucleic Acid Amplification Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Isothermal Nucleic Acid Amplification Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Isothermal Nucleic Acid Amplification Market Facts & Figures by Country
  • 3.3.1 North America Isothermal Nucleic Acid Amplification Sales by Country
  • 3.3.2 North America Isothermal Nucleic Acid Amplification Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Isothermal Nucleic Acid Amplification Market Facts & Figures by Country
  • 3.4.1 Europe Isothermal Nucleic Acid Amplification Sales by Country
  • 3.4.2 Europe Isothermal Nucleic Acid Amplification Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Isothermal Nucleic Acid Amplification Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Isothermal Nucleic Acid Amplification Sales by Region
  • 3.5.2 Asia Pacific Isothermal Nucleic Acid Amplification Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Isothermal Nucleic Acid Amplification Market Facts & Figures by Country
  • 3.6.1 Latin America Isothermal Nucleic Acid Amplification Sales by Country
  • 3.6.2 Latin America Isothermal Nucleic Acid Amplification Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Isothermal Nucleic Acid Amplification Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Isothermal Nucleic Acid Amplification Sales by Country
  • 3.7.2 Middle East and Africa Isothermal Nucleic Acid Amplification Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Isothermal Nucleic Acid Amplification Historic Market Analysis by Type

• 4.1 Global Isothermal Nucleic Acid Amplification Sales Market Share by Type (2016-2021)
• 4.2 Global Isothermal Nucleic Acid Amplification Revenue Market Share by Type (2016-2021)
• 4.3 Global Isothermal Nucleic Acid Amplification Price by Type (2016-2021)

5 Global Isothermal Nucleic Acid Amplification Historic Market Analysis by Application

• 5.1 Global Isothermal Nucleic Acid Amplification Sales Market Share by Application (2016-2021)
• 5.2 Global Isothermal Nucleic Acid Amplification Revenue Market Share by Application (2016-2021)
• 5.3 Global Isothermal Nucleic Acid Amplification Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 PreAnalytiX
  • 6.1.1 PreAnalytiX Corporation Information
  • 6.1.2 PreAnalytiX Description and Business Overview
  • 6.1.3 PreAnalytiX Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 PreAnalytiX Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.1.5 PreAnalytiX Recent Developments/Updates
• 6.2 Meridian Bioscience
  • 6.2.1 Meridian Bioscience Corporation Information
  • 6.2.2 Meridian Bioscience Description and Business Overview
  • 6.2.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Meridian Bioscience Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.2.5 Meridian Bioscience Recent Developments/Updates
• 6.3 Eiken Chemical
  • 6.3.1 Eiken Chemical Corporation Information
  • 6.3.2 Eiken Chemical Description and Business Overview
  • 6.3.3 Eiken Chemical Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Eiken Chemical Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.3.5 Eiken Chemical Recent Developments/Updates
• 6.4 Lucigen
  • 6.4.1 Lucigen Corporation Information
  • 6.4.2 Lucigen Description and Business Overview
  • 6.4.3 Lucigen Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Lucigen Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.4.5 Lucigen Recent Developments/Updates
• 6.5 OptiGene
  • 6.5.1 OptiGene Corporation Information
  • 6.5.2 OptiGene Description and Business Overview
  • 6.5.3 OptiGene Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 OptiGene Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.5.5 OptiGene Recent Developments/Updates
• 6.6 NEB
  • 6.6.1 NEB Corporation Information
  • 6.6.2 NEB Description and Business Overview
  • 6.6.3 NEB Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 NEB Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.6.5 NEB Recent Developments/Updates
• 6.7 Biomerieux
  • 6.6.1 Biomerieux Corporation Information
  • 6.6.2 Biomerieux Description and Business Overview
  • 6.6.3 Biomerieux Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Biomerieux Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.7.5 Biomerieux Recent Developments/Updates
• 6.8 Abbott
  • 6.8.1 Abbott Corporation Information
  • 6.8.2 Abbott Description and Business Overview
  • 6.8.3 Abbott Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Abbott Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.8.5 Abbott Recent Developments/Updates
• 6.9 Quidel Corporation
  • 6.9.1 Quidel Corporation Corporation Information
  • 6.9.2 Quidel Corporation Description and Business Overview
  • 6.9.3 Quidel Corporation Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Quidel Corporation Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.9.5 Quidel Corporation Recent Developments/Updates
• 6.10 Promega
  • 6.10.1 Promega Corporation Information
  • 6.10.2 Promega Description and Business Overview
  • 6.10.3 Promega Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Promega Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.10.5 Promega Recent Developments/Updates
• 6.11 Hologic
  • 6.11.1 Hologic Corporation Information
  • 6.11.2 Hologic Isothermal Nucleic Acid Amplification Description and Business Overview
  • 6.11.3 Hologic Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Hologic Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.11.5 Hologic Recent Developments/Updates
• 6.12 Ustar
  • 6.12.1 Ustar Corporation Information
  • 6.12.2 Ustar Isothermal Nucleic Acid Amplification Description and Business Overview
  • 6.12.3 Ustar Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Ustar Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.12.5 Ustar Recent Developments/Updates
• 6.13 Grifols
  • 6.13.1 Grifols Corporation Information
  • 6.13.2 Grifols Isothermal Nucleic Acid Amplification Description and Business Overview
  • 6.13.3 Grifols Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Grifols Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.13.5 Grifols Recent Developments/Updates
• 6.14 ThermoFisher
  • 6.14.1 ThermoFisher Corporation Information
  • 6.14.2 ThermoFisher Isothermal Nucleic Acid Amplification Description and Business Overview
  • 6.14.3 ThermoFisher Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 ThermoFisher Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.14.5 ThermoFisher Recent Developments/Updates
• 6.15 Nugen
  • 6.15.1 Nugen Corporation Information
  • 6.15.2 Nugen Isothermal Nucleic Acid Amplification Description and Business Overview
  • 6.15.3 Nugen Isothermal Nucleic Acid Amplification Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Nugen Isothermal Nucleic Acid Amplification Product Portfolio
  • 6.15.5 Nugen Recent Developments/Updates

7 Isothermal Nucleic Acid Amplification Manufacturing Cost Analysis

• 7.1 Isothermal Nucleic Acid Amplification Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Isothermal Nucleic Acid Amplification
• 7.4 Isothermal Nucleic Acid Amplification Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Isothermal Nucleic Acid Amplification Distributors List
• 8.3 Isothermal Nucleic Acid Amplification Customers

9 Isothermal Nucleic Acid Amplification Market Dynamics

• 9.1 Isothermal Nucleic Acid Amplification Industry Trends
• 9.2 Isothermal Nucleic Acid Amplification Growth Drivers
• 9.3 Isothermal Nucleic Acid Amplification Market Challenges
• 9.4 Isothermal Nucleic Acid Amplification Market Restraints

10 Global Market Forecast

• 10.1 Isothermal Nucleic Acid Amplification Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Isothermal Nucleic Acid Amplification by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Isothermal Nucleic Acid Amplification by Type (2022-2027)
• 10.2 Isothermal Nucleic Acid Amplification Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Isothermal Nucleic Acid Amplification by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Isothermal Nucleic Acid Amplification by Application (2022-2027)
• 10.3 Isothermal Nucleic Acid Amplification Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Isothermal Nucleic Acid Amplification by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Isothermal Nucleic Acid Amplification by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List